A phase I trial of GWP-42006 in patients with autism spectrum disorders.
Latest Information Update: 25 Jan 2017
At a glance
- Drugs Cannabidivarin (Primary)
- Indications Pervasive child development disorders
- Focus Adverse reactions
- 25 Jan 2017 New trial record.